DATA PLANS
Download historical data for 20 million indicators using your browser.
Subscription Plans
|
Features
API GATEWAY
Direct access to our data from your apps using any programing language.
Features
|
Documentation
Already a user?
Login
Light Mode
Dark Mode
Calendar
News
Markets
Currencies
Stocks
Commodities
Bonds
Crypto
Earnings
Holidays
Indicators
Inflation Rate
Interest Rate
Unemployment Rate
GDP Growth
GDP per Capita
GDP Value
Current Account
Credit Rating
Wages Growth
Gold Reserves
Government Debt
Crude Oil Production
Gasoline Prices
Heatmap Table
More Indicators
Countries
United States
China
Japan
Canada
Australia
Brazil
Russia
India
Euro Area
United Kingdom
Germany
France
Italy
Spain
Switzerland
Singapore
More Countries
Forecasts
Countries
Indicators
Currencies
Stocks
Commodities
Bonds
Crypto
Charles River Laboratories | CRL - Ebitda
Chart
Quotes
Financials
1Y
5Y
10Y
25Y
MAX
Chart
Column
Line
Area
Spline
Splinearea
Trend
Average(4)
Histogram
Variance
Mean
Maximum
Minimum
Compare
Export
API
Embed
Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.
Features
Questions?
Contact us
Already a Member?
Login
The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.
API Features
Documentation
Interested?
Click here to contact us
Please Paste this Code in your Website
width
height
Preview
Charles River Laboratories
Charles River Laboratories reported $246.02M in EBITDA for its fiscal quarter ending in March of 2023.
Ebitda
Change
Date
Agilent
A:US
USD 472M
33M
Mar/2023
Align Technology
ALGN:US
USD 137.34M
20.48M
Mar/2023
AmerisourceBergen
ABC:US
USD 982.51M
170.33M
Mar/2023
Bruker
BRKR:US
USD 151.3M
9.9M
Mar/2023
Catalent
CTLT:US
USD 242M
85M
Dec/2022
Charles River Laboratories
CRL:US
USD 246.02M
4.67M
Mar/2023
CVS Health
CVS:US
USD 4.86B
86M
Mar/2023
Danaher
DHR:US
USD 2.32B
538M
Mar/2023
Dentsply International
XRAY:US
USD 145M
6M
Mar/2023
Hologic
HOLX:US
USD 342.3M
7.1M
Mar/2023
Illumina
ILMN:US
USD 15M
73M
Mar/2023
Incyte Corp
INCY:US
USD 48.82M
62.76M
Mar/2023
IQVIA Holdings Inc
IQV:US
USD 765M
16M
Mar/2023
Laboratory Of America
LH:US
USD 595.5M
280.9M
Mar/2023
Lonza Group
LONN:SW
CHF 1.21B
220M
Dec/2022
McKesson
MCK:US
USD 1.29B
108M
Mar/2023
Novartis
NOVN:VX
USD 4.72B
217M
Mar/2023
Pfizer
PFE:US
USD 8.01B
683M
Mar/2023
Quest Diagnostics
DGX:US
USD 431M
129M
Mar/2023
Thermo Fisher Scientific
TMO:US
USD 2.56B
204M
Mar/2023
United Therapeutics
UTHR:US
USD 297.7M
97.7M
Mar/2023
Veradigm Inc
MDRX:US
USD 38.81M
29.61M
Sep/2022
Walgreens Boots Alliance
WBA:US
USD 1.31B
143M
Dec/2022
Waters
WAT:US
USD 205.58M
112.02M
Mar/2023
West Pharmaceutical Services
WST:US
USD 199.7M
13.3M
Mar/2023
Financials
Stock Price
Assets
Cash and Equivalent
Cost of Sales
Current Assets
Current Liabilities
Debt
EBIT
EBITDA
Employees
EPS Earnings Per Share
Equity Capital and Reserves
Gross Profit on Sales
Interest Expense on Debt
Interest Income
Loan Capital
Market Capitalization
Net Income
Operating Expenses
Operating Profit
Ordinary Share Capital
PE Price to Earnings
Pre-Tax Profit
Sales Revenues
Selling and Administration Expenses
Stock
Trade Creditors
Trade Debtors